Resumen
The prevalence of obesity and diabetes is epidemic. Severe insulin resistance (defined as the need for ≥ 200 units of insulin per day to achieve glycemic control) is commonly seen with obesity and can complicate diabetes management. The management of patients with diabetes who have severe insulin resistance is difficult, and at times frustrating, and requires a multifaceted approach. Weight loss is the best treatment option, which can be a challenging task for patients to achieve and maintain. Medications that decrease insulin needs like metformin, thiazolidinediones, or pramlintide may help, but some patients also need high doses of insulin. This article reviews these different treatment options and provides practical advice on weight loss, use of insulin sensitizers, and use of U-500 insulin.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 163-171 |
| Número de páginas | 9 |
| Publicación | Postgraduate Medicine |
| Volumen | 122 |
| N.º | 1 |
| DOI | |
| Estado | Published - ene 2010 |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- General Medicine
Huella
Profundice en los temas de investigación de 'Managing highly insulin-resistant diabetes mellitus: Weight loss approaches and medical management'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver